All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32858802

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32858802	D25E	IN	gag-pol	HIV Infections	D G L	View
2	32858802	D278A	IN	gag-pol	HIV Infections	D G L	View
3	32858802	F100Y	IN	gag-pol	HIV Infections	D G L	View
4	32858802	I151V	IN	gag-pol	HIV Infections	D G L	View
5	32858802	K136Q	IN	gag-pol	HIV Infections	D G L	View
6	32858802	K136T	IN	gag-pol	HIV Infections	D G L	View
7	32858802	K14R	IN	gag-pol	HIV Infections	D G L	View
8	32858802	L101I	IN	gag-pol	HIV Infections	D G L	View
9	32858802	M50I	IN	gag-pol	HIV Infections	D G L	View
10	32858802	R269K	IN	gag-pol	HIV Infections	D G L	View
11	32858802	S283G	IN	gag-pol	HIV Infections	D G L	View
12	32858802	T112V	IN	gag-pol	HIV Infections	D G L	View
13	32858802	T125A	IN	gag-pol	HIV Infections	D G L	View
14	32858802	T206S	IN	gag-pol	HIV Infections	D G L	View
15	32858802	T218I	IN	gag-pol	HIV Infections	D G L	View
16	32858802	V201I	IN	gag-pol	HIV Infections	D G L	View
17	32858802	V234I	IN	gag-pol	HIV Infections	D G L	View
18	32858802	V31I	IN	gag-pol	HIV Infections	D G L	View
19	32858802	V72I	IN	gag-pol	HIV Infections	D G L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.